Professional development Vacancies

Bonviva (ibandronic acid)

17.11.2015 Updated 22.10.2019 3717 views

By MoH of Ukraine order No. 748 of 12.11.15, the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product containing ibandronic acid, namely the product BONVIVA®, solution for injection, were approved with amendments and additions to the sections of the instructions: “Contraindications”, “Interaction with other medicinal products and other forms of interaction”, “Special precautions for use”, “Use during pregnancy or breastfeeding”, “Ability to influence reaction time when driving or operating other machinery”, “Children”, “Overdose”, “Adverse reactions”.

List of medicinal products containing ibandronic acid as an active substance, authorized for medical use in Ukraine: